| |
| |
|
| Insider
Information: |
Hacksell Uli |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
115,549 |
|
|
| Direct
Value |
$8,602 |
|
|
|
Indirect Value
|
$1,970,110 |
|
|
| Total
Shares |
135,549 |
|
|
| Total
Value |
$1,978,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
|
2015-02-17 |
0 |
2015-02-17 |
115,549 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
Director |
2017-06-09 |
20,000 |
2016-12-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • – |
2017-06-09 |
4 |
B |
$0.42 |
$4,200 |
D/D |
10,000 |
20,000 |
2.31 |
- |
|
| AVTX |
Avalo Therapeutics, Inc |
Director |
– • – |
2016-12-10 |
4 |
B |
$1.07 |
$10,700 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-02-17 |
4 |
AS |
$34.30 |
$1,028,868 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-02-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-02-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-02-17 |
4 |
OE |
$1.55 |
$46,500 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-01-14 |
4 |
AS |
$33.98 |
$1,019,430 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-01-14 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2015-01-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-12-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-12-15 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-12-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-12-15 |
4 |
AS |
$31.00 |
$929,916 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-11-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-11-24 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-11-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-11-24 |
4 |
AS |
$29.28 |
$878,397 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
AS |
$24.15 |
$724,530 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
0 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-10-08 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
OE |
$2.00 |
$60,000 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
145,549 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
CEO |
• • – |
2014-09-10 |
4 |
AS |
$27.36 |
$820,821 |
I/I |
(30,000) |
115,549 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
